Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

The deadline for applications for any Oxford-administered scholarships, including the RDM Scholars Programme, has now passed. There are still some funded studentships and where funding is available the details and deadlines for application are provided in the individual project advert.

Antanaviciute Group - Computational biology and machine learning for characterising spatial tissue niches and cellular signalling across space and time of human immune system development Agne Antanaviciute
Koohy Group - Applications of multi-omics and AI to better understand T cell immunity and antigen-specificity Hashem Koohy
Kini Group - A network approach to identifying novel genes causing neurodevelopmental disorders- The SATB pathway Usha Kini
Tyler Group - Development and Application of Novel Magnetic Resonance Imaging Approaches for the Assessment of Multi-System Disease (Funding available) Damian Tyler
Chakraverty Group - Design of advanced haematopoietic stem cell and T cell therapies (Funding available) Ronjon Chakraverty
Antoniades Group - Cross-talk between adipose tissue and the cardiovascular system in humans: From novel imaging biomarkers development to drug target discovery Charalambos Antoniades
Douglas Group - Functional coronary artery disease genetics - defining the function of new causal atherosclerosis genes from CAD GWAS loci using in vitro and in vivo models Gillian Douglas
Karpe Group - Human fat distribution and metabolic disease Fredrik Karpe
Leeson Group - Imaging in Preventive Cardiology Research Paul Leeson
Lygate Group - Realising the therapeutic potential of creatine and homoarginine in heart disease Craig Lygate
Piechnik Group - Myocardial functional T1 mapping – Advanced cardiac magnetic resonance imaging techniques Stefan Piechnik
Reilly Group - Adverse myocardial remodelling in cardiac fibrosis and atrial fibrillation Svetlana Reilly
Tzima Group - Go with the flow---the why and how of cardiovascular disease Ellie Tzima
Watkins Group – Creating genetic therapies for inherited heart muscle disease Hugh Watkins
Drakesmith Group - Iron Biology Hal Drakesmith
Goriely Group - De Novo Mutations and Human Disease Anne Goriely
Higgs Group - Laboratory of Gene Regulation Douglas Higgs
Mead Group - Unravelling intratumoural heterogeneity in Myeloproliferative Neoplasms Adam Mead
Twigg/Wilkie Group - Building the skull – normal and abnormal development Stephen Twigg
Nerlov Group - Hematopoietic Stem Cell Genetics Claus Nerlov
Patel Group - Origins of Genotoxic metabolism and the DNA damage response in stem and cancer cells KJ Patel
Toepfer Group - Elucidating the role of disease modifying gene variants in inherited cardiomyopathies using induced pluripotent stem cell derived cardiomyocytes and CRISPR/Cas-9. Christopher Toepfer
Chapman Group - Homologous recombination in genome maintenance and cancer prevention (Funding available) Ross Chapman
Christodoulides Group– Deciphering the role of white and brown adipocytes in metabolic disease. Constantinos Christodoulides
Davis Group - Therapeutic opportunities emerging from studies of immune checkpoints Simon Davis
David Hodson Group - Understanding how glucagon-like peptide-1 (GLP1) and gastric inhibitory polypeptide (GIP) receptors contribute to metabolism in complex tissues David Hodson
Valkovič Group - Non-invasive cardiac metabolism assessment using ultra-high field (7T) MR Spectroscopy Ladislav Valkovic
Akbar Group - Generating extracellular vesicles for therapeutic Immunomodulation and building tools to determine their diagnostic potential. Naveed Akbar